The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Stratified Care vs Step Care Strategies for Migraine: The Disability in Strategies of Care (DISC) Study:A Randomized Trial
Abstract
CONTEXT: Various guidelines recommend different strategies for selecting and sequencing acute treatments for migraine. In step care, treatment is escalated after first-line medications fail. In stratified care, initial treatment is based on measurement of the severity of illness or other factors. These strategies for migraine have not been rigorously evaluated. OBJECTIVE: To compare the clinical benefits of 3 strategies: stratified care, step care within attacks, and step care across attacks, among patients with migraine. DESIGN AND SETTING: Randomized, controlled, parallel-group clinical trial conducted by the Disability in Strategies Study group from December 1997 to March 1999 in 88 clinical centers in 13 countries. PATIENTS: A total of 835 adult migraine patients with a Migraine Disability Assessment Scale (MIDAS) grade of II, III, or IV were analyzed as the efficacy population; the safety analysis included 930 patients. INTERVENTIONS: Patients were randomly assigned to receive (1) stratified care (n = 279), in which patients with MIDAS grade II treated up to 6 attacks with aspirin, 800 to 1000 mg, plus metoclopramide, 10 mg, and patients with MIDAS grade III and IV treated up to 6 attacks with zolmitriptan, 2.5 mg; (2) step care across attacks (n = 271), in which initial treatment was with aspirin, 800 to 1000 mg, plus metoclopramide, 10 mg. Patients not responding in at least 2 of the first 3 attacks switched to zolmitriptan, 2.5 mg, to treat the remaining 3 attacks; and (3) step care within attacks (n = 285), in which initial treatment for all attacks was with aspirin, 800 to 1000 mg, plus metoclopramide, 20 mg. Patients not responding to treatment after 2 hours in each attack escalated treatment to zolmitriptan, 2.5 mg. MAIN OUTCOME MEASURES: Headache response, achieved if pain intensity was reduced from severe or moderate at baseline to mild or no pain at 2 hours; and disability time per treated attack at 4 hours for all 6 attacks, compared among the 3 groups. RESULTS: Headache response at 2 hours was significantly greater across 6 attacks in the stratified care treatment group (52.7%) than in either the step care across attacks group (40.6%; P<.001) or the step care within attacks group (36.4%; P<.001). Disability time (6 attacks) was significantly lower in the stratified care group (mean area under the curve [AUC], 185.0 mm. h) than in the step care across attacks group (mean AUC, 209.4 mm. h; P<.001) or the step care within attacks group (mean AUC, 199.7 mm. h; P<.001). The incidence of adverse events was higher in the stratified care group (321 events) vs both step care groups (159 events in across-attack group; 217 in within-attack group), although most events were of mild-to-moderate intensity. CONCLUSION: Our results indicate that as a treatment strategy, stratified care provides significantly better clinical outcomes than step care strategies within or across attacks as measured by headache response and disability time. JAMA. 2000;284:2599-2605.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Silberstein, S. D. (2000) · Neurology · doi:10.1212/wnl.55.6.754 · Cited by 1,360
Generalized linear mixed models a pseudo-likelihood approach
Wolfinger, R., & O'connell, M. (1993) · Journal of Statistical Computation and Simulation · doi:10.1080/00949659308811554 · Cited by 1,271
A Controlled Trial of a Critical Pathway for Treatment of Community-Acquired Pneumonia
Marrie, T. J. (2000) · JAMA · doi:10.1001/jama.283.6.749 · Cited by 731
(1997) · JAMA · doi:10.1001/jama.277.11.925 · Cited by 668
Stewart, W. F., Lipton, R. B., Kolodner, K. B., Sawyer, J., Lee, C., & Liberman, J. N. (2000) · Pain · doi:10.1016/s0304-3959(00)00305-5 · Cited by 622
Self-citationAn international study to assess reliability of the Migraine Disability Assessment (MIDAS) score
Stewart, W. F., Lipton, R. B., Whyte, J., Dowson, A., Kolodner, K., Liberman, J. N., & Sawyer, J. (1999) · Neurology · doi:10.1212/wnl.53.5.988 · Cited by 621
Self-citationStewart, W., Lipton, R., Kolodner, K., Liberman, J., & Sawyer, J. (1999) · Cephalalgia · doi:10.1046/j.1468-2982.1999.019002107.x · Cited by 556
Self-citationMedical Consultation for Migraine: Results From the American Migraine Study
Lipton, R. B., Stewart, W. F., & Simon, D. (1998) · Headache: The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.1998.3802087.x · Cited by 370
Self-citationPryse-Phillips, W. E. M., Dodick, D. W., Edmeads, J. G., Gawel, M. J., Nelson, R. F., Purdy, R. A., Robinson, G., Stirling, D., & Worthington, I. (1997) · Europe PMC (PubMed Central) · Cited by 214
Optimizing the dose of zolmitriptan (Zomig,* 311C90) for the acute treatment of migraine
Rapoport, A. M., Ramadan, N. M., Adelman, J. U., et al. (1997) · Neurology · doi:10.1212/wnl.49.5.1210 · Cited by 157
(2008) · European Neurology · doi:10.1159/000116818 · Cited by 150
Clinical efficacy and tolerability of 2.5 mg zolmitriptan for the acute treatment of migraine
Solomon, G. D., Cady, R. K., Klapper, J. A., Earl, N. L., Saper, J., & Ramadan, N. M. (1997) · Neurology · doi:10.1212/wnl.49.5.1219 · Cited by 141
A Practical Guide to the Management and Prevention of Migraine
Diener, H., Kaube, H., & Limmroth, V. (1998) · Drugs · doi:10.2165/00003495-199856050-00006 · Cited by 70
The 1997 Asthma Management Guidelines and Therapeutic Issues Relating to the Treatment of Asthma
Georgitis, J. W. (1999) · CHEST Journal · doi:10.1378/chest.115.1.210 · Cited by 70
Disability Assessment as a Basis for Stratified Care
Lipton, R. B. (1998) · Cephalalgia · doi:10.1177/0333102498018s2208 · Cited by 56
Self-citationSaper, J. R., Silberstein, S. D., & Gordon, C. (1993) · Cited by 27
Cited by
Migraine — Current Understanding and Treatment
Goadsby, P. J., Lipton, R. B., & Ferrari, M. D. (2002) · New England Journal of Medicine · doi:10.1056/nejmra010917 · Cited by 1,918
Self-citationAilani, J., Burch, R. C., Robbins, M. S., & the Board of Directors of the American Headache Society (2021) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.14153 · Cited by 766
Blumenfeld, A., Varon, S., Wilcox, T., Buse, D., Kawata, A., Manack, A., Goadsby, P., & Lipton, R. (2011) · Cephalalgia · doi:10.1177/0333102410381145 · Cited by 627
“Responses to these items are summed for a total score, which can be categorized into one of four grades of headache-related disability: grade I, little or no disability (score of 0–5); grade II, mild disability (score of 6–10); grade III, moderate disability (score of 11–20) (36); and grade IV, severe disability (scor…”
BackgroundMethodInfluentialSelf-citationDodick, D. W. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30478-1 · Cited by 557
Ferrari, M. D., Goadsby, P. J., Burstein, R., Kurth, T., Ayata, C., Charles, A., Ashina, M., van den Maagdenberg, A. M. J. M., & Dodick, D. W. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00328-4 · Cited by 500
Metadata
- Authors
- Lipton, R. B., Stewart, W. F., Stone, A. M., Láinez, M. J. A., & Sawyer, J. P. C.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2000-11-22
- Volume
- 284
- Issue
- 20
- Pages
- 2599
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2156846198
- Cited by
- 363
- References
- 17
- FWCI
- 17.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.